Ubs Group Ag Immutep LTD Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$1.54 - $2.62 $1,848 - $3,144	1,200 New	1,200 $2,000
Q4 2022 Feb 08, 2023	SELL	$1.6 - $2.53 $14,771 - $23,356	-9,232 Reduced 87.22%	1,353 $2,000
Q3 2022 Nov 10, 2022	BUY	$1.56 - $2.29 $16,512 - $24,239	10,585 New	10,585 $17,000
Q2 2022 Aug 10, 2022	SELL	$1.96 - $3.09 $12,653 - $19,949	-6,456 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.3 - $3.61 $10,506 - $16,490	4,568 Added 241.95%	6,456 $18,000
Q4 2021 Feb 14, 2022	BUY	$3.09 - $4.81 $5,623 - $8,754	1,820 Added 2676.47%	1,888 $6,000
Q3 2021 Nov 15, 2021	SELL	$3.17 - $4.39 $4,025 - $5,575	-1,270 Reduced 94.92%	68 $0
Q2 2021 Aug 13, 2021	SELL	$3.02 - $5.21 $13,680 - $23,601	-4,530 Reduced 77.2%	1,338 $5,000
Q1 2021 May 12, 2021	SELL	$2.37 - $3.68 $23,626 - $36,685	-9,969 Reduced 62.95%	5,868 $18,000
Q4 2020 Feb 11, 2021	BUY	$1.64 - $5.69 $13,321 - $46,219	8,123 Added 105.3%	15,837 $50,000
Q3 2020 Nov 12, 2020	BUY	$1.05 - $1.89 $2,035 - $3,664	1,939 Added 33.58%	7,714 $13,000
Q2 2020 Jul 31, 2020	BUY	$0.67 - $1.31 $2,933 - $5,735	4,378 Added 313.39%	5,775 $6,000
Q1 2020 May 01, 2020	BUY	$0.72 - $3.03 $1,005 - $4,232	1,397 New	1,397 $1,000
Q3 2019 Nov 14, 2019	SELL	$1.27 - $1.78 $6,706 - $9,400	-5,281 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$1.74 - $2.16 $9,188 - $11,406	5,281 New	5,281 $10,000
Q1 2019 May 14, 2019	SELL	$1.97 - $2.57 $13,642 - $17,797	-6,925 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.84 - $3.9 $12,742 - $27,007	6,925 New	6,925 $13,000
Q2 2018 Aug 14, 2018	SELL	$1.77 - $2.95 $9,609 - $16,015	-5,429 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$1.64 - $2.13 $977 - $1,269	596 Added 12.33%	5,429 $10,000
Q4 2017 Feb 14, 2018	BUY	$1.32 - $2.72 $6,379 - $13,145	4,833	4,833 $8,000

Others Institutions Holding IMMP

# of Institutions

Shares Held

2.41M

Call Options Held

526K

Put Options Held

222K

View Full List

About IMMUTEP Ltd

Ticker IMMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,000
Market Cap $172M
Description
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...

More about IMMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account